Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Open-label, Flexible-dose Adjunctive Bromocriptine for Patients With Schizophrenia and Prediabetes

NCT03575000 is registered in ClinicalTrials.gov with VA Pittsburgh Healthcare System as lead sponsor.

NCT NCT03575000
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03575000 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Open-label, Flexible-dose Adjunctive Bromocriptine for Patients With Schizophrenia and Prediabetes
Lead sponsor
VA Pittsburgh Healthcare System
Phase
Phase 4
Overall status
Not yet recruiting
Start date
January 1, 2026
Completion date
July 31, 2026
Enrollment
15 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

prediabetes, schizophrenia